Brief: Starcoin Signed MoU For Genetic Epidemiology, Physiology Of Cardiovascular Disease & Its Risk Factors, Others
Oct 17 (Reuters) - Starcoin Group Ltd 0399.HK: SIGNED MOU FOR GENETIC EPIDEMIOLOGY AND PHYSIOLOGY OF CARDIOVASCULAR DISEASE AND ITS RISK FACTORS, OTHERS ENTERED INTO MOU WITH SUPERNOVA FOR DEVELOPING AND MANAGING BLOCKCHAIN-BASED SYSTEMS, OTHERS Further company coverage: 0399.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Starcoin
See all newsBrief: Starcoin Group Says Trading In Shares Of Co Will Suspend From 6 May
Brief: Starcoin Enters Non-Binding Memorandum Of Understanding With Marvel Nice
Brief: Starcoin Group Enters MoU For Strategic Cooperation With Huamei Haibo Biotechnology (Chongqing)
Brief: Starcoin Group Says Unit, Others Enters Deal For Brazilian Gold Mine RWA Tokenization
Brief: Starcoin Group, Newbridge And Conflux Foundation Entered MoU